Eli Lilly has signed its second pipeline-building deal in two days, reaching an agreement to buy in vivo CAR-T developer Orna ...

The restaurant, located in the former Carrabba’s Italian Grill at 5110 Poplar Ave., officially opens with a ribbon-cutting ...

Eli Lilly to buy Orna Therapeutics, which focuses on ‘in vivo’ CAR-T for autoimmune diseases, for $2.4 billion ...

It's the latest in a string of science-focused deals that the pharmaceutical giant has made over the past 12 months as its ...

Find Living Standards India Latest News, Videos & Pictures on Living Standards India and see latest updates, news, information from NDTV.COM. Explore more on Living Standards India.

Android remains the top choice for India’s mass-market smartphone users despite the increasing popularity of the iPhone.

As its GLP-1 rival goes after compounders, Eli Lilly and Co. started the week with news beyond its diabetes and obesity franchise. The company, which disclosed a new agreement with Innovent Biologics ...

Eli Lilly and Company (NYSE:LLY) is one of the best medical research stocks to buy according to hedge funds. On February 10, Eli Lilly and Company (NYSE:LLY) was upgraded to Buy from Hold by Freedom ...

The deal gets Lilly access to Orna’s in vivo CAR T technology. The biotech’s lead asset, which has yet to start clinical ...

XLV gains, top S&P 500 winners/losers, and key earnings & deal news on AstraZeneca, CVS, Moderna & Lilly—read now.

Eli Lilly announced an acquisition of an innovative new autoimmune drug.

Strategic capital raising features participation from New York-based investment firm Blue Sky Capital, as well as Sovereign Family Offices from ...